Healthcare

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

1 day ago   |   Xconomy

Three biotech companies collectively raised $584 million in their initial public offerings last week, continuing a streak of IPOs that has the healthcare sector playing a...
Read more ...

Pharmaceutical Sales Representative - Ashfield Commercial & Medical Services - San Diego, CA

5 days ago   |   San Diego Biotechnology   |   8 articles

Ashfield Healthcare has a long-standing partnership with Genentech, a leading Biotechnology company, across Commercial, Patient Solutions and Medical Affairs...From Ashfield...
Read more ...

A Medical Sublime

7 days ago   |   Springer

Abstract Inspired by a passage from Kate Chopin's The Awakening , this article considers the possibility of a “medical sublime.” It works through a history of the sublime in...
Read more ...

Living Dis/Artfully with and in Illness

7 days ago   |   Springer

Abstract This article experiments with multimedia storytelling to re-vision difference outside biomedical and humanistic frames by generating new understandings of living...
Read more ...

BioMeT and Algorithm Challenges: A Proposed Digital Standardized Evaluation Framework

12 days ago   |   EMBS

Technology is advancing at an extraordinary rate. Continuous flows of novel data are being generated with the potential to revolutionize how we better identify, treat, manage...
Read more ...

AI in Medical Imaging Informatics: Current Challenges and Future Directions

14 days ago   |   EMBS

This paper reviews state-of-the-art research solutions across the spectrum of medical imaging informatics, discusses clinical translation, and provides future directions for...
Read more ...

New Xconomy Special Report: Biopharma and Tech Innovators Summer 2020

New Xconomy Special Report: Biopharma and Tech Innovators Summer 2020

15 days ago   |   Xconomy

Even during the most difficult of times, the life science sector continues to push forward with innovation. The recent rapid progression of drug development, diagnostic tests...
Read more ...

Survival neural networks for time-to-event prediction in longitudinal study

15 days ago   |   Springer

Abstract Time-to-event prediction has been an important practical task for longitudinal studies in many fields such as manufacturing, medicine, and healthcare. While most of...
Read more ...

Bio Roundup: Gilead's Pionyr Grab, Relay to IPO, Unicorn Sana & More

Bio Roundup: Gilead's Pionyr Grab, Relay to IPO, Unicorn Sana & More

18 days ago   |   Xconomy

Uncertainty related to the continued spread of the pandemic continued to consume most of the oxygen in the room this week, but life sciences news outside of that arena...
Read more ...

FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products

FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products

19 days ago   |   Xconomy

A “new playbook” is needed to ensure consistent chemistry, manufacturing, and controls reviews for gene therapy products, the lack of which is hindering the development of...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

After Biologic COVID-19 Drug OK'd in India, Equillium Plans a US Test

After Biologic COVID-19 Drug OK'd in India, Equillium Plans a US Test

The drug that Equillium licensed from India-based pharma giant Biocon has received authorization for emergency use in that country in patients hospitalized with COVID-19. The... Read more ...

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

A Blueprint Medicines cancer drug candidate currently under FDA review will have the marketing muscle of Roche behind it if it wins regulatory approval. The two companies are... Read more ...

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Have you had your say yet? The 2020 National Xconomy Awards represent the very best our life science industry has to offer. It is our privilege to recognize emerging companies... Read more ...

New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on...

New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health

Miss Xconomy's Xcelerating Life Sciences Boston: Biopharma's Future in Digital Health event or want to revisit the insightful content? Our new podcast and special report... Read more ...

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More

At the year's start Thousand Oaks, CA-based Amgen closed a strategic collaboration with BeiGene, investing $2.8 billion to gain a presence in what's becoming an ever-more... Read more ...

Scientists Successfully Demonstrate a New Experiment in the Search for...

Scientists Successfully Demonstrate a New Experiment in the Search for Theorized ‘Neutrinoless' Process

The CUPID-Mo detector is installed in the Edelweiss cryostat at Modane Underground Laboratory in France. Nuclear physicists affiliated with the U.S. Department of Energy's... Read more ...

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

Three biotech companies collectively raised $584 million in their initial public offerings last week, continuing a streak of IPOs that has the healthcare sector playing a... Read more ...

Inverse Liquid Solid Chromatography to Evaluate Drug Interactions with...

Abstract Body‐on‐a‐chip and organ‐on‐a‐chip systems utilize polydimethylsiloxane because of the relative suitability of the material for fabrication of microfluidic channels... Read more ...

Expression, homology modeling and enzymatic characterization of a new...

Β-mannanase can hydrolyze β-1,4 glycosidic bond of mannan by the manner of endoglycosidase to generate mannan-oligosaccharides. Currently, β-mannanase has been widely applied... Read more ...

De novo resveratrol production through modular engineering of an Escherichia...

Resveratrol is a plant secondary metabolite with diverse, potential health-promoting benefits. Due to its nutraceutical merit, bioproduction of resveratrol via microbial... Read more ...